Berman Capital Advisors’s Quest Diagnostics DGX Stock Holding History

Berman Capital Advisors’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$125K	Buy	861 +210	+32%	+$30.7K	0.02%	377
2021 Q2	$86K	Buy	651 +186	+40%	+$24.4K	0.01%	420
2021 Q1	$59K	Sell	465 -23	-5%	-$2.83K	0.01%	424
2020 Q4	$57K	Sell	488 -303	-38%	-$36.9K	0.01%	373
2020 Q3	$89K	Buy	791 +2	+0.3%	+$236	0.03%	245
2020 Q2	$89K	Buy	789 +26	+3%	+$2.76K	0.02%	235
2020 Q1	$59K	Buy	763 +17	+2%	+$1.76K	0.02%	262
2019 Q4	$79K	Buy	746 +427	+134%	+$44.5K	0.02%	255
2019 Q3	$34K	Hold	319	–	–	0.01%	371
2019 Q2	$32K	Buy	319 +103	+48%	+$9.9K	0.01%	398
2019 Q1	$19K	Buy	216 +143	+196%	+$12.4K	0.01%	469
2018 Q4	$6K	Buy	+73	New	+$6.84K	﹤0.01%	619

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FMI

Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Berman Capital Advisors's DGX Position: Q3 2021 in Review

Berman Capital Advisors increased its Quest Diagnostics (DGX) stake by 32% in Q3 2021, buying an estimated $30.7K and bringing the position to 861 shares worth $125K. The position accounts for 0.02% of the portfolio, ranked #377.

Berman Capital Advisors first reported a position in DGX in Q4 2018 and has held it in 12 quarters since. 838 funds tracked by Wall St. Rank hold DGX as of Q3 2021.

Berman Capital Advisors held 861 shares of Quest Diagnostics worth $125K as of Q3 2021.
Berman Capital Advisors bought 210 Quest Diagnostics shares in Q3 2021, an estimated $30.7K.
Quest Diagnostics made up 0.02% of Berman Capital Advisors's portfolio in Q3 2021, its #377 holding.
Berman Capital Advisors first reported a position in Quest Diagnostics in Q4 2018 and has held it in 12 quarters since.
838 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2021.

Based on Berman Capital Advisors's 13F filing for Q3 2021, filed 7 Oct 2021.